SWEDEHEART Analysis: Uninterrupted Oral Anticoagulants Should Be ‘Preferred Strategy’ for PCI
New findings from the SWEDEHEART registry suggest that uninterrupted oral anticoagulant (OAC) therapy should be the preferred strategy in patients on these medicines undergoing percutaneous coronary intervention (PCI).